1. Home
  2. BDTX vs CMT Comparison

BDTX vs CMT Comparison

Compare BDTX & CMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • CMT
  • Stock Information
  • Founded
  • BDTX 2014
  • CMT 1996
  • Country
  • BDTX United States
  • CMT United States
  • Employees
  • BDTX N/A
  • CMT N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • CMT Electronic Components
  • Sector
  • BDTX Health Care
  • CMT Consumer Discretionary
  • Exchange
  • BDTX Nasdaq
  • CMT Nasdaq
  • Market Cap
  • BDTX 181.4M
  • CMT 147.1M
  • IPO Year
  • BDTX 2020
  • CMT N/A
  • Fundamental
  • Price
  • BDTX $2.76
  • CMT $17.48
  • Analyst Decision
  • BDTX Strong Buy
  • CMT
  • Analyst Count
  • BDTX 5
  • CMT 0
  • Target Price
  • BDTX $13.40
  • CMT N/A
  • AVG Volume (30 Days)
  • BDTX 914.3K
  • CMT 22.6K
  • Earning Date
  • BDTX 08-07-2025
  • CMT 08-05-2025
  • Dividend Yield
  • BDTX N/A
  • CMT N/A
  • EPS Growth
  • BDTX N/A
  • CMT N/A
  • EPS
  • BDTX 0.25
  • CMT 1.08
  • Revenue
  • BDTX $70,000,000.00
  • CMT $276,176,000.00
  • Revenue This Year
  • BDTX N/A
  • CMT N/A
  • Revenue Next Year
  • BDTX N/A
  • CMT $1.14
  • P/E Ratio
  • BDTX $11.03
  • CMT $16.12
  • Revenue Growth
  • BDTX N/A
  • CMT N/A
  • 52 Week Low
  • BDTX $1.20
  • CMT $12.25
  • 52 Week High
  • BDTX $6.75
  • CMT $18.71
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 52.31
  • CMT 58.58
  • Support Level
  • BDTX $2.22
  • CMT $17.14
  • Resistance Level
  • BDTX $2.84
  • CMT $17.28
  • Average True Range (ATR)
  • BDTX 0.20
  • CMT 0.43
  • MACD
  • BDTX -0.01
  • CMT 0.03
  • Stochastic Oscillator
  • BDTX 72.00
  • CMT 80.07

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About CMT Core Molding Technologies Inc

Core Molding Technologies Inc operates in the engineered materials market as one operating segment as a molder of thermoplastic and thermoset structural products. It produces and sells molded products for varied markets, including medium and heavy-duty trucks, automobiles, power sports, construction and agriculture, building products, and other industrial markets. The processes include compression molding of sheet molding compound (SMC), resin transfer molding (RTM), liquid molding of dicyclopentadiene (DCPD), spray-up and hand-lay-up, direct long-fiber thermoplastics (D-LFT) and structural foam, and structural web injection molding (SIM). It operates operates in Columbus, Ohio; Gaffney, South Carolina; Winona, Minnesota; Matamoros and Escobedo, Mexico; and Cobourg, Ontario, Canada.

Share on Social Networks: